1-11 of 11
Weiping Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Upfront Autologous Stem Cell Transplant at First Complete Remission in Patients with Advanced-Stage Extra-Nodal NK/T Cell Lymphoma: A Multicenter Retrospective Study

Shaoxuan Hu, Linjun Zhao, Weiping Liu, Wenrong Huang, Shunan Qi, Xiaopei Wang, Yuqin Song, Yexiong Li, Jun Zhu
Journal: Blood
Blood (2023) 142 (Supplement 1): 3597.
https://doi.org/10.1182/blood-2023-184486
Published: 2023
Journal Articles

Daratumumab, Bortezomib, and Dexamethasone (D-Vd) Versus Bortezomib and Dexamethasone (Vd) Alone in Chinese Patients with Relapsed/Refractory Multiple Myeloma: Final Analysis of the Phase 3 Lepus Study

Weijun Fu, Xue Gai, Weiping Liu, Xi Chen, Canchan Cui, Jin Lu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6719.
https://doi.org/10.1182/blood-2023-181025
Published: 2023
Journal Articles

Role of Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma in the First Complete or Partial Remission: A Propensity Score-Matched Analysis

Hongye Gao, Weiping Liu, Yuqin Song, Jun Zhu
Journal: Blood
Blood (2022) 140 (Supplement 1): 7703–7704.
https://doi.org/10.1182/blood-2022-155596
Published: 2022
Journal Articles

Subcutaneous Daratumumab Plus Pomalidomide and Dexamethasone (D-Pd) Versus Pomalidomide and Dexamethasone (Pd) Alone in Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Overall Survival Results from the Phase 3 Apollo Study

Meletios A. Dimopoulos, Evangelos Terpos, Mario Boccadoro, Sosana Delimpasi, Meral Beksac, Eirini Katodritou, Philippe Moreau, Luca Baldini, Argiris Symeonidis, Jelena Bila, Albert Oriol, Maria-Victoria Mateos, Hermann Einsele, Ioannis Orfanidis, Tobias Kampfenkel, Weiping Liu, Michele Kosh, NamPhuong Tran, Robin Carson, Pieter Sonneveld
Journal: Blood
Blood (2022) 140 (Supplement 1): 7272–7274.
https://doi.org/10.1182/blood-2022-163483
Published: 2022
Journal Articles

Comparative Analysis of Clinicopathological Features and Genetic Landscape of Relapsed/ Refractory and Effectively Treated Extranodal Nasal NK/ T Cell Lymphoma

Limin Gao, Huifang Li, Qi-Jie Jian, Wenyan Zhang, Sha Zhao, Kai Wang, Weiping Liu
Journal: Blood
Blood (2021) 138 (Supplement 1): 1384.
https://doi.org/10.1182/blood-2021-149335
Published: 2021
Journal Articles

Daratumumab, Bortezomib, Dexamethasone (D-Vd) Versus Bortezomib and Dexamethasone (Vd) in Relapsed or Refractory (RR) Multiple Myeloma (MM): Pooled Subgroup Analysis of Lepus and Castor

Jin Lu, Weijun Fu, MDPhD, Wei Li, MD, Jianda Hu, MDPhD, Gang An, MD PhD, Yafei Wang, Chengcheng Fu, Lijuan Chen, MDPhD, Jie Jin, MD PhD, Xinan Cen, Zheng Ge, MDPhD, Zhen Cai, MD PhD, Ting Niu, MD PhD, Andrew Spencer, DM, Katja Weisel, MD, María-Victoria Mateos, MD PhD, Ajay Nooka, MDMPH, Ming Qi, MD PhD, Steven Sun, Xue Gai, Weiping Liu, Xue Yang, Xiaojun Huang
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–41.
https://doi.org/10.1182/blood-2020-136108
Published: 2020
Journal Articles

Clinicopathology, Disease Progression/Transformation and Genomic Alterations of Indolent T-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract

Limin Gao, Weiping Liu, Wenyan Zhang, Sha Zhao, Yueqiang Song, Jinwei Hu, Kai Wang, Haiyan Wu
Journal: Blood
Blood (2020) 136 (Supplement 1): 36.
https://doi.org/10.1182/blood-2020-139080
Published: 2020
Journal Articles

Yf-H-2015005, a New CXCR4 Antagonist, in the Mobilization of Hematopoietic Stem Cells in Patients with Non-Hodgkin Lymphoma: A Randomized-Controlled Phase 3 Study

Weiping Liu, Yufu Li, Quanshun Wang, Kaiyang Ding, Hang Su, Yue-rong Shuang, Sujun Gao, Hongmei Jing, Ye Chai, Dehui Zou, Hui Liu, Chunling Wang, Lihong LIU, Yicheng Zhang, Jinying Lin, Haiyan Zhu, Meixia Shang, Xiaoyan Yan, Chen Yao, Fengyuan Chang, Jun Zhu, MD, Yuqing Song
Journal: Blood
Blood (2019) 134 (Supplement_1): 590.
https://doi.org/10.1182/blood-2019-125456
Published: 2019
Journal Articles

CD19 CAR T Cell Product Exhibits High Remission Rate in Adult Relapsed and/or Refractory B-Cell Non-Hodgkin Lymphoma

Zhitao Ying, MD PhD, Wen Wang, MD, Xiaopei Wang, MD, Wen Zheng, MD, Ningjing Lin, MD PhD, Meifeng Tu, MD PhD, Yan Xie, MD PhD, Lingyan Ping, MD PhD, Chen Zhang, MD PhD, Weiping Liu, MD PhD, Lijuan Deng, MD PhD, Ming Hao, Su Yang, Yan Zhou, BSc, James Li, Yuqin Song, MD PhD, Jun Zhu, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5388.
https://doi.org/10.1182/blood-2018-99-114527
Published: 2018
Journal Articles

The Intracellular TCR Signaling Pathway As a Novel Therapeutic Target in AITL Patients

Yalu Liu, Ning Ding, MD, Xiaogan Wang, MD, Lijuan Deng, MD, Lingyan Ping, Yunfei Shi, Wen Zheng, Ningjing Lin, Xiaopei Wang, Meifeng Tu, Yan Xie, Weiping Liu, Zhitao Ying, Chen Zhang, Zhengying Pan, Xi Wang, Yuqin Song, MD, Jun Zhu, BS
Journal: Blood
Blood (2017) 130 (Supplement 1): 1461.
https://doi.org/10.1182/blood.V130.Suppl_1.1461.1461
Published: 2017
Journal Articles

Frequent Activating Mutations Of JAK-STAT Pathway Genes In Natural Killer Cell Lymphomas

Can Kucuk, PhD, Bei Jiang, Xiaozhou Hu, M.D., Philippe Gaulard, MD, Wenyan Zhang, Wenming Xiao, PhD, Louis M. Staudt, MD., Ph.D., Javeed Iqbal, M.Sc, PhD, Weiwei Zhang, Adam Cornish, Pinar Kavak, Can Alkan, Ph.D., Qiang Gong, Qunpei Yang, Hong Sun, Francesco d'Amore, Sirpa Leppa, Weiping Liu, Timothy McKeithan, MD, PhD, Wing C. Chan, MD
Journal: Blood
Blood (2013) 122 (21): 812.
https://doi.org/10.1182/blood.V122.21.812.812
Published: 2013